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Guanylate kinase (GMPK) is a nucleoside monophos-
phate kinase that catalyzes the reversible phosphoryl
transfer from ATP to GMP to yield ADP and GDP. In
addition to phosphorylating GMP, antiviral prodrugs
such as acyclovir, ganciclovir, and carbovir and antican-
cer prodrugs such as the thiopurines are dependent on
GMPK for their activation. Hence, structural informa-
tion on mammalian GMPK could play a role in the de-
sign of improved antiviral and antineoplastic agents.
Here we present the structure of the mouse enzyme in
an abortive complex with the nucleotides ADP and
GMP, refined at 2.1 Å resolution with a final crystallo-
graphic R factor of 0.19 (Rfree  0.23). Guanylate kinase
is a member of the nucleoside monophosphate (NMP)
kinase family, a family of enzymes that despite having a
low primary structure identity share a similar fold,
which consists of three structurally distinct regions
termed the CORE, LID, and NMP-binding regions. Pre-
vious studies on the yeast enzyme have shown that these
parts move as rigid bodies upon substrate binding. It
has been proposed that consecutive binding of sub-
strates leads to “closing” of the active site bringing the
NMP-binding and LID regions closer to each other and
to the CORE region. Our structure, which is the first of
any guanylate kinase with both substrates bound, sup-
ports this hypothesis. It also reveals the binding site of
ATP and implicates arginines 44, 137, and 148 (in addi-
tion to the invariant P-loop lysine) as candidates for
catalyzing the chemical step of the phosphoryl transfer.
Guanylate kinase (GMPK,1 ATP:GMP phosphotransferase,
EC 2.7.4.8) is a critical enzyme for the biosynthesis of GTP and
dGTP by catalyzing the phosphoryl transfer from ATP to
(d)GMP resulting in ADP and (d)GDP (1, 2). GMPK also plays
an important role in the recycling of the second messenger
cGMP (3). In addition to these physiological roles, GMPK is
essential for the activation of prodrugs used for the treatment
of cancers and viral infections (4, 5). Therefore, it is medically
important to elucidate its enzymatic mechanism and the struc-
tural basis for its nucleotide specificity. Our current structural
understanding of this enzyme is derived from the apo- and
GMP-bound structures of the yeast GMPK (6) and from anal-
ogy to other nucleoside monophosphate (NMP) kinases (7).
It has been shown that the induced fit mechanism (8) plays
an important role in NMP kinases, of which adenylate kinase is
the best characterized (9–11). NMP kinases catalyze phospho-
ryl transfer by binding both donor and acceptor nucleotides to
form a ternary complex. Comparison of the crystal structures of
nucleotide-free adenylate kinase to the one in which a single
substrate is bound (AMP or ATP) and to the complex in which
both substrates are present revealed the conformational
changes that occur along the reaction coordinate: from an open
unbound enzyme via a partially closed intermediate in which a
single substrate is present to the fully closed form in the pres-
ence of both substrates. These substrate-induced conforma-
tional changes can be described as resulting from rigid body
movements of three regions relative to each other: a CORE
region, a LID region, and an NMP-binding region.
Prior to this work, a structure of GMPK in which both sub-
strate-binding sites are occupied was not available. Because of
low sequence identity among the various NMP kinases and
because of known structural differences between them (e.g. the
NMP-binding domain of adenylate kinase (9) is all helical,
whereas that of yeast GMPK consists of a four-stranded
-sheet and two short helices (12)), it is difficult to interpolate
with high precision from a structure of one NMP kinase to a
related one. Therefore, we set out to elucidate the crystal struc-
ture of the fully closed conformation of guanylate kinase. In
addition, because the medically most relevant GMPK would be
the human enzyme, we commenced our work with this enzyme.
Contrary to published reports that found the human GMPK to
be inactive when expressed in Escherichia coli (13), we were
successful in obtaining large quantities of active human GMPK
(14). Unfortunately, crystals grown with the human enzyme
were not suitable for x-ray diffraction experiments. However,
we were successful in obtaining crystals of the mouse GMPK in
complex with GMP and ADP (mGMPKGMP-ADP). Here we re-
port this structure with an emphasis on the conformational
changes of the enzyme that occur because of the presence of
nucleotides in both substrate-binding sites. The very high se-
quence similarity between the mGMPK and human GMPK
(88% identity, 93% homology) assures that the information we
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have gained on the mouse enzyme is directly transferable to the
human enzyme.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—The mGMPK coding region
(13) was cloned in the bacterial expression vector pGEX-RB (15) as a
glutathione S-transferase-GMPK fusion protein. Expression was in-
duced by 0.1 mM isopropyl-1-thio--D-galactopyranoside, and the cells
were grown 14 h after induction at 32 °C. A purification protocol was
developed that included a glutathione-Sepharose column (Pharmacia
Corp.), cleavage of the fusion protein with thrombin on the column,
passage of the cleaved protein via a benzamidine column (to bind the
thrombin), and a gel filtration column (S75; Pharmacia Corp.). The total
yield of 400 mg of protein from 6 liters of culture was obtained. Prior to
crystallization mGMPK was dialyzed against 25 mM KCl, 25 mM Tris/
HCl, pH 7.5, 10 mM dithiothreitol.
Dynamic light scattering experiments indicated the existence of a
single 20-kDa species in solution, which is consistent with the calcu-
lated molecular mass of 22 kDa. This result is in agreement with the
gel filtration profile.
Crystallization and X-ray Data Collection—The crystals were grown
at room temperature using hanging drops containing equal volumes of
protein solution and reservoir solution. The protein solution contained
10 mg/ml of mGMPK, 2 mM GMP, 2 mM ADP, and 5 mM MgCl2, whereas
the reservoir contained 38–46% (w/v) polyethylene glycol 4000, 0.1 M
sodium citrate, pH 5.6, and 0.1–0.2 M ammonium acetate. Tetragonal
crystals appeared within 4–6 days and exceeded the size of 240 200
200 m. 100% mineral oil (light white; Sigma M3516) was used as
cryoprotectant. Attempts to obtain crystals in which AppNHp replaces
ADP were not successful.
The data were collected at 100 K on a Rigaku RAXIS IIc detector, by
using focused copper K radiation from a Rigaku RU-H2R rotating
anode x-ray generator at a power of 50 kV, 100 mA. The crystal dif-
fracted to 2.1 Å resolution, and the data were processed with XDS (16).
The model used for molecular replacement was the 1.9 Å structure of
yGMPK crystallized with GMP (6). Refinement was done in CNS (17)
for x-ray data collected within resolution range of 30–2.1 Å. The final
crystallographic R and Rfree are 0.19 and 0.23, respectively.
RESULTS
Quality of Structure—Mouse guanylate kinase crystallized
in space group P41212 (a  67.2 Å, c  108.7 Å) with one
molecule/asymmetric unit. The data to a 2.1 Å resolution were
collected at cryogenic temperature. The final structure consists
of a single polypeptide chain (amino acids 5–194 of 198 were
modeled; weak or no density was observed for both termini),
197 water molecules, the nucleotides GMP and ADP, and a
potassium ion. The crystallographic R factor is 0.19 for reflec-
tions within the resolution range of 20–2.1 Å. All main chain
dihedral angles are found in favorable and allowed regions of
the Ramachandran plot (18). Table I shows data collection and
refinement statistics.
Overall Structure—The overall fold of the mouse guanylate
kinase is very similar to that of the yeast enzyme (6). Consisting
of 198 amino acid residues, mGMPK is 11 residues longer than
yGMPK; two of these amino acids are located at the N terminus,
and nine are located at the C-terminal part of the protein.
mGMPK is built from a total of eight -helices and two -sheets
that form three structurally and functionally distinct parts.
These are the CORE region (residues 5–31, 97–123, and 165–194;
helices 1, 4, 7, and 8; strands 1, 7, 8, and 9), the
NMP-binding region (residues 37–89; helices 2 and 3; strands
3, 4, 5, and 6), and the LID region (residues 126–156;
helices 5 and 6) (Fig. 1). These parts are interconnected with
four hinges.
The division of mGMPK to encompass these three regions is
based on the analysis of three GMPK complex structures: apo-
enzyme or enzyme with one or two nucleotides bound. Although
the relative conformations of the regions (CORE, LID, and
NMP-binding regions) are different between the three struc-
tures, comparison of the same region among the three struc-
tures reveals low RMSD (Fig. 2). Our nomenclature differs
from that previously established in two aspects. First, we de-
fine a bigger LID region that includes residues 126–156 (pre-
viously defined only as seven residues) (6). Second, we define
hinges based on higher RMSDs of residues in the interface
between regions and not on B factors as previously done. We
believe that this RMSD-based classification represents a less
biased approach than a one based solely on B factor analysis,
avoiding the requirement for a hinge to be mobile in a static
crystal structure.
TABLE I
Data collection and refinement statistics
Data collection
X-ray source Rotating anode,   1.5412 Å
Unit cell (Å) a  67.2, c  108.7
Space group P41212
No. molecules/asymmetric unit 1
Resolution limit (Å) 20–2.1
Measured reflections 105,017
Unique reflections 14,942
Completeness (%; overall/last shell) 98.4/99.9




Resolution limit (Å) 20–2.1
No. reflections (working/free) 13,491/1,451 (9.6%)
Rcryst (overall/last shell)
b 0.19/0.22
Rfree (overall/last shell) 0.23/0.30
No. residues/non-H atoms 190/1476
RMSD from ideal geometry (Å)
Bond length 0.012
Angle distances 1.538
Estimated coordinate error (Å) 0.28
Ramachandran plot statistics
Residues in most favored regions 90.5%
Residues in allowed regions 9.5%
Residues in disallowed regions 0.0%
a Rsym  ¥I  I/¥I.
b Rcryst  ¥Fobs  Fcalc/¥Fobs. 10% randomly omitted reflections
were used for Rfree.
FIG. 1. Ribbon diagram of mGMPKGMP-ADP. The different regions
of the enzyme are color-coded. cyan, CORE region; red, NMP-binding
region; green, LID region; yellow, interconnected with four hinges. The
nucleotides ADP and GMP (red) and the potassium ion (green sphere)
are also shown. All structural figures were generated using MOL-
SCRIPT (41) and RASTER3D (42).
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In our structure, there are two hinges between each pair of
contacting domains. The NMP-binding and CORE regions are
connected through hinge 1 (residues 32–36) and hinge 2 (resi-
dues 90–96; part of helix 3), whereas the CORE and LID
regions are linked by hinge 3 (residues 124–125) and hinge 4
(residues 157–164; part of helix 6).
Of the nine additional C-terminal residues found in mGMPK
in comparison with yGMPK, five residues had traceable elec-
tron density and were modeled as helix 8. The functions of the
additional C-terminal residues found in mammalian (13), bac-
terial (19), and plant (20) GMPKs are not clear.
Conformational Changes Induced by Binding of Nucleo-
tides—The structure presented here is the first of a guanylate
kinase in which both nucleotide-binding sites are occupied. The
mGMPK in complex with GMP and ADP is in a closed confor-
mation, which allows us, by comparing it with previously re-
ported open (yGMPKapo) and partially closed (yGMPKGMP)
structures of yGMPK (6), to delineate the effect of each nucle-
otide on the conformation of the enzyme (Fig. 3).
Nucleotide-induced movements in NMP kinases affect the
relative orientation of rigid regions while maintaining to a
large extent the overall fold of each individual region. If one
uses the hand as an analogy to NMP kinase structure, the
CORE region would be the palm of the hand, the LID region
would be the thumb, and the NMP-binding region would be the
fingers. Analogously to fingers and thumb that close over the
palm of the hand to make a fist, in the presence of nucleotides
the LID and NMP-binding regions move toward each other by
means of “hinges” that connect the two regions to the CORE
region. The high folding similarities of these relatively rigid
regions, the CORE, NMP-binding, and LID regions, between
the mGMPK and yGMPK make it possible to overlay regions
between the two species. Superposition of all three models
(yGMPKapo, yGMPKGMP, and mGMPKGMP-ADP) based only on
the CORE region clearly shows a closing of individual regions
with successive binding of nucleotides. The nucleotide-free
yGMPK structure is characterized by the farthest distance
between the LID and NMP-binding regions, which we name the
open conformation of the kinase. This conformation appears
highly flexible, consistent with the presence of two molecules in
the asymmetric units of the yGMPKapo structure that differ
slightly in the relative conformations of the LID and NMP-
binding regions (6). This higher mobility of the nucleotide-free
enzyme is also manifested by a structure having higher aver-
age main chain B factors (Fig. 4).
The enzyme with only GMP bound, as compared with the
apo-GMPK structure, is characterized by a significant move-
ment of the NMP-binding region toward the LID region, with a
concomitant smaller move of the LID region in the same direc-
tion (i.e. not toward the NMP-binding region). However, the
overall effect of GMP binding is to bring these two regions
closer to each other and form the partially closed enzyme con-
formation. A detailed analysis of the change in conformation
from the apo-bound to the GMP-bound enzyme has been pre-
sented recently (6).
In the presence of nucleotides at both binding sites, both the
LID and NMP-binding regions are pulled closer to each other
and to the CORE region, yielding an even more compact con-
FIG. 2. Overlay of each individual
region from the three GMPK struc-
tures. Calculations of superposition mat-
rices were done according to the residues
specified in text, with the largest RMSD
for all three regions being between
mGMPKGMP-ADP and yGMPKapo. a, over-
lay of LID region. b, overlay of NMP-bind-
ing region. c, overlay of CORE region.
Highest RMSD values were: for the
CORE region, 1.62 Å; for the NMP-bind-
ing region, 0.76 Å; and for the LID region,
0.86 Å. The regions from yGMPKapo are
displayed in green, those from yGMP-
KGMP are in blue, and those from mGMP-
KGMP-ADP are in magenta.
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formation. This closed conformation is also characterized by a
lower overall B factor in comparison with the apo- and GMP-
bound structures, with a significant reduction of apparent mo-
bility of the LID region (Fig. 4). The increased rigidity of the
ternary complex structure can be accounted for by the newly
formed interactions between residues of the LID region and the
nucleotides (Fig. 5), as well as a direct interaction between the
LID and NMP-binding regions (salt bridge between Glu140 and
Arg44).
GMP-binding Site—The major interactions involved in the
binding of GMP in our mGMPKGMP-ADP ternary complex are
similar to those previously reported for the yGMPKGMP struc-
FIG. 3. Three conformational states
of GMPK. Overlays of yGMPKapo (green),
yGMPKGMP (blue), and mGMPKGMP-ADP
(magenta) are shown. The nucleotide-de-
pendent conformational states are open in
the apo-structure, partially closed in the
presence of GMP, and fully closed in the
presence of GMP and ADP.
FIG. 4. Main chain B factor plot. Deviation from the average B factor as a function of residue number is plotted for yGMPKapo (green),
yGMPKGMP (blue), and mGMPKGMP-ADP (magenta). The domains and secondary structure elements are shown at the bottom. yGMPKapo
crystallized with two different molecules in asymmetric unit, although only one more open form is shown here for clarity.
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ture (Fig. 5, b and d). Specificity between AMP and GMP is
accomplished by discriminating base interactions: Ser37 that
interacts with the guanine carbonyl at position 6 (an amino
group in adenine), and by carboxylic acids Glu72 and Asp103
that interact with the guanine amino group at position 3 (not
present in adenine). Notably, Glu72 makes a bidentate interac-
FIG. 5. Binding sites of GMP and ADP. a and b, distance map showing residues involved in binding of ADP (a) and GMP (b). For clarity,
backbone atoms of the P-loop are shown in green. Residues that are making interactions not previously observed in the yGMPKGMP structure are
shown in red. For example, the Asp101 interaction with the GMP ribose observed in the mGMPKADP-GMP complex is made possible by the additional
closing of the structure as a result of ADP binding and is absent in the yGMPKGMP structure (Asp
98 in yGMPK). The distances are in angstroms.
c and d, ball-and-stick representation of the ADP-binding (c) and GMP-binding (d) sites. e, stereoview of the active site with residues involved in
phosphate interactions shown in red and the nucleotides shown in blue.
Closed Confirmation of Mouse Guanylate Kinase30240
 at M














tion with two hydrogen bond donors; N1, which is protonated in
guanine (but unprotonated in adenine), and the amine group at
position 2 of the base. In adenylate kinase (21, 22), specificity
for adenine is obtained because of the presence of a glutamine
in the analogous position of the glutamic acid in guanylate
kinase, also via a bidentate interaction with N1 (this time an
hydrogen bond acceptor) and the amine group at position 6.
Our structure supplies an explanation for the rather limited
success in changing the substrate specificity of mGMPK to
accept AMP as a substrate by replacing the glutamic acid with
a glutamine (23) (see “Discussion”).
A strong peak in the electron density map close to atom N7
of the guanine base was modeled as a potassium ion (modeling
of this density with a smaller atom resulted in a very low B
factor; note that KCl was present in the crystallization buffer).
Additionally, the distances between this six-coordinated metal
to its ligand are in agreement with the expected values for
potassium (24). The importance of this interaction for GMP
binding is not clear and was not observed in the yGMPKGMP
structure.
For the yeast GMPK it has been reported that dGMP is a
poor substrate in comparison with GMP, with a 4-fold higher
Km and a 8-fold reduced kcat (25). The residue responsible for
this difference is Asp101 (conserved between mouse and yeast),
which interacts with the 2-hydroxyl group of the ribose of
GMP.
Similarly to the yGMPKGMP structure, in the mGMPKGMP-ADP
structure we observed tyrosines 53 and 81 and arginines 41 and
44 to interact with the phosphate group of GMP. However, the
interaction of these arginines with GMP is strengthened in the
mGMPKGMP-ADP structure in comparison with the yGMPKGMP
structure. For example, Arg44, which corresponds to Arg41 in the
yeast structure and which makes only a weak hydrogen bond in
that structure (3.4 Å), makes a stronger (2.6 Å) interaction with
phosphate of GMP in mGMPKGMP-ADP. Not present in the
yGMPKGMP complex structure is the interaction between the
LID arginine (Arg148) and the phosphate group of GMP that we
observed in the mGMPK ternary complex. Formation of the lat-
ter arginine-GMP interaction and strengthening of the former is
made possible by the conformational changes induced by the
binding of both substrates that bring the LID and NMP-binding
regions closer to each other. These facts, as well as a position that
potentially enables these arginine side chains to interact with
both substrates concomitantly (i.e. the GMP phosphate and the
-phosphate of ATP), make these two residues potential candi-
dates for taking part in catalyzing the phosphoryl transfer.
ADP Binding—Our mGMPKGMP-ADP structure represents
the enzyme in an abortive complex in which a substrate (GMP)
and a product (ADP) are bound. Inhibition of GMPK activity by
GMP has been attributed to the formation of this complex,
which slows down but does not arrest the release of ADP (25).
The presence of ADP provides us with important information
on the conformation of the enzyme in the presence of two
nucleotides and on the interactions made with the phosphoryl
donor. The binding site of ADP/ATP is located between the LID
and CORE regions (Fig. 5e). The adenine base is held in posi-
tion through the strictly conserved Arg133 (a stacking interac-
tion), the side chain of Asn171, and the main chain carbonyl of
Asp172 (Fig. 5, a and b).
As was previously observed in other NMP kinase structures,
the ATP/ADP-ribose does not directly interact with any protein
atom but rather is stabilized by several water molecules. Phos-
phate group binding is through the P-loop, a sequence highly
conserved among ATP-binding proteins (26). The main chain
atoms of this motif, localized in the loop between strand 1 and
helix 1, provide hydrogen-bonding interactions with the
-phosphate. Additionally, the -phosphate interacts with the
side chains of Ser18 and Lys17 (both from the P-loop) and Arg137
(from the LID region). The latter basic amino acids could po-
tentially also interact with a -phosphate and in this way play
a role in catalyzing the chemical step of phosphoryl transfer.
The -phosphate is within hydrogen bond distances from the
side chains of Thr19 and Arg137 (Arg137 also interacts with the
-phosphate).
DISCUSSION
The ability of guanylate kinase to catalyze the transfer of a
phosphoryl group from ATP to GMP to yield GDP is important
both physiologically and medicinally. Physiologically, through
being a component of the metabolic pathway of GTP and dGTP
formation, GMPK plays a vital role in DNA and RNA synthesis
(2). Additionally, the recycling of the second messenger cGMP
and the overall concentrations of GTP, which is involved in the
regulation of numerous pathways, is dependent on GMPK ac-
tivity (3). The medicinal importance of GMPK is in the activa-
tion pathway of guanosine analog prodrugs. Examples are mer-
captopurine and thioguanine, which are used for the treatment
of various types of cancers; acyclovir and ganciclovir, which are
used for the treatment of herpes infections and in cancer sui-
cide gene therapy; and carbovir, which are used against HIV (4,
5, 27). Despite its importance, up to now there was no structure
of a mammalian GMPK, and the available structures that
focused on the yeast enzyme had no substrates or only a single
substrate present in complex with the enzyme. To better un-
derstand the active site properties of the mammalian enzyme
and to characterize the enzyme in the presence of nucleotides
at both substrate-binding sites, we solved the crystal structure
of the mouse guanylate kinase in complex with GMP and ADP.
Role of Arginines from LID and NMP-binding Regions—The
LID region in most NMP kinases (eukaryotic thymidylate
kinases being an exception (28)) contains several arginine res-
idues that have been shown to participate in catalyzing phos-
phoryl transfer by direct interactions with the -phosphate of
ATP (29). In the nucleotide-free and GMP-bound yGMPK
structures, this region is too far away to fulfill this catalytic
role. Upon binding of ATP, a conformational change takes place
that brings the LID to a position where its arginines (Arg137
and Arg148) can directly interact with the phosphates of the
nucleotide. In the mGMPKGMP-ADP structure, Arg
137 interacts
with the - and -phosphates of ADP, and Arg148 interacts with
the GMP phosphate. The analogous arginines in adenylate
kinase have been shown by mutational analysis to be essential
for catalysis (30). Additionally, structural studies performed
with Dictyostelium discoideum uridylate kinase have also dem-
onstrated the importance of these LID arginines (29, 31).
Notably, in the structure of uridylate kinase in a complex that
mimics the transition state, it was observed that the arginine
that would correspond to Arg148 of mGMPK interacts with the
transferred phosphoryl group. It is therefore likely that Arg148,
which we observed only to interact with GMP, would actually
interact with the -phosphate of ATP (we have ADP in our
structure) or would potentially act as a clamp by interacting
with both the phosphates of GMP and ATP. Additionally, this
residue is held in its position by hydrogen bonding with Ser13
(CORE) and Ser144 (LID) through NH1 and N, respectively. It
is possible that the presence of ATP would favor an interaction
with -phosphate of ATP instead of Ser13. On the other hand,
Arg44, which is part of NMP-binding region, is also positioned
to potentially interact with the -phosphate of ATP, suggesting
its possible involvement in directly catalyzing the chemical
step of phosphoryl transfer. This residue is additionally stabi-
lized in our structure with the previously mentioned interac-
tion with Glu140. Ambiguity that arises, if Arg44, Arg148, or both
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directly interact with the transferred phosphoryl group, cannot
be resolved by our structure.
Inherent Flexibility of the Enzyme—In the analysis by
Blaszczyk et al. (6) of the conformational changes that occur in
yGMPK upon GMP binding, it was noticed that the tempera-
ture factors of residues in helix 3, which compose one of hinges
between the NMP-binding region and the CORE region, have
increased significantly in comparison with those seen in the
yGMPKapo structure (6). Blaszczyk et al. propose that helix 3
acts like a spring in the movement of the NMP-binding region
and speculate that the ternary complex will likewise have
increased mobility in this helix. Higher mobility of the analo-
gous helix in adenylate kinase was also observed by Muller et
al. (32). However, we observe below average B factors for this
helix in the mGMPKGMP-ADP structure (Fig. 4). Consistent with
our observation are low B factors for the analogous helix seen
in a number of uridylate kinase ternary complex structures (29,
31). We conclude that the higher B factors for this helix seen in
the yGMPKGMP structure may be due to the inherent flexibility
of the enzyme when only a single substrate is present and that
the more rigid, fully closed structure we observe in the presence
of both nucleotides is a true representation of this state. Im-
portantly, our results and those of others (29, 31, 32) question
the proposal that helix 3 serves as a spring to prevent the
ternary complex from getting trapped at an energy minimum.
Base Specificity of NMP-binding Site—Our structure also
serves to rationalize the limited success achieved in work in
which the goal was to change the substrate specificity of
mGMPK to accept AMP instead of GMP as substrate (23). This
was attempted by mutating the two carboxylic acids that in-
teract with the guanine base to uncharged residues, as are
present in adenylate kinase. The E72Q/D103N double mutant,
although able to functionally complement adenylate kinase
temperature-sensitive bacterial strains, possessed only mar-
ginally improved kinetics with AMP. This we attribute to the
inability of the introduced glutamine in position 72 of mGMPK
to mimic its counterpart in adenylate kinase. Although in both
nucleoside monophosphate kinases there is an interaction be-
tween the side chain of this residue to N1 of guanine/adenine,
in mGMPK Glu72 interacts with the NH2 at position 2, whereas
in adenylate kinase the glutamine analogous to Glu72 interacts
with the NH2 at position 6. As a result of this difference (an
interaction with NH2 at position 2 or 6), despite the presence of
a glutamine in mGMPK instead of Glu72 in the double mutant,
this residue will not be able to interact with the NH2 at posi-
tion 6 of the adenine ring. The position of the Glu72 side chain
will be constrained by the proximity to Thr83, making a shift
from proximity to position 2 to position 6 of the ring not possi-
ble. Using our structure we are now in a position to design
mutations that would take this fact into consideration (for
example, mutating Thr83 to a glycine to provide room for the
introduced glutamine at position 72 to make a bidentate inter-
action with the adenine ring).
The closed conformation of the ternary complex shows that
ADP is mostly solvent exposed, whereas GMP is mostly buried.
This would suggest an ordered substrate-binding and product
release mechanism in which GMP binds first, followed by ATP,
and after the chemical step, ADP leaves the enzyme prior to
GDP (an ordered sequential mechanism). However, recent
kinetic results are consistent with a random sequential mech-
anism, although they do not rule out an ordered mechanism
(25). To reconcile a random sequential mechanism for GMPK
with our closed conformation structure of mGMPKADP-GMP, we
must speculate that the closed structure we observe is the most
stable of the ternary complex conformations but that the mol-
ecule undergoes opening (“breathing”) to transiently produce a
more open structure. It is to this transient open structure that
substrates bind in a random order or from which products
dissociate in a random order. In conflict with such a random
sequential mechanism are recent results on the herpes simplex
virus thymidine kinase using isothermal titration calorimetry
that demonstrated ordered binding to this kinase (33). Planned
isothermal titration calorimetry experiments with mGMPK
will resolve this ambiguity.
Binding of Therapeutically Important Nucleotide Analogs—
The purine base analogs 6-mercaptopurine and 6-thioguanine
have been in clinical use for nearly 50 years (34), but it is still
not possible to pinpoint a single biochemical pathway for thio-
purine cytotoxicity. One mechanism would be due to the incor-
poration of thiopurine in DNA, which induces DNA damage,
such as single strand breaks, DNA-protein cross-links, inter-
strand cross-links, and sister chromatid exchanges (35–39).
This mechanism requires the sequential phosphorylation of
thiopurine prodrugs to their activated triphosphorylated forms.
Guanylate kinase is the rate-limiting enzyme in the phospho-
rylation pathway of thiopurines, with a Km of over 2 mM for
6-thioguanosine monophosphate (6T-MP) and a maximal veloc-
ity of 3% of that with GMP (40). We modeled 6T-MP in the
active site of mGMPK to try to understand the structural
reasons that make this GMP analog such a poor substrate. The
sulfur atom, which substitutes for the oxygen atom found in
guanine, is predicted, if bound in an identical fashion to GMP,
to make hydrogen bonds with Ser37 and Thr83. An explanation
for the poor activity of GMPK with 6T-MP might be steric clash
with these alcohol side chains. To test this hypothesis, we made
mutants in which the serine and the threonine, singly and in
combination, were replaced by an alanine or a glycine. How-
ever, kinetic analysis of these mutants showed no improved
activity with 6T-MP as a substrate.2 An alternative explana-
tion for the poor activity of 6T-MP implicates the hydrogen
bonding capability of this analog with the enzyme. GMP makes
a bidentate interaction with Glu72, but because 6T-MP is pre-
dicted to exist mostly as the tautomer in which the sulfur atom
is protonated (an SH group) and the ring nitrogen at position
1 is unprotonated, this interaction cannot be obtained with the
thiopurine analog. This suggests that replacing the conserved
Glu72 with a glutamine would enable such an interaction to
take place. Whether such a variant of mGMPK in combination
with mutations of Ser37 and Thr83 will efficiently phosphoryl-
ate thioguanines is currently being tested.
In summary, we present the structure of the first mamma-
lian guanylate kinase in complex with GMP and ADP. Com-
parison of the structure with the available yeast guanylate
kinase structures allows us to better understand the conforma-
tional changes that occur along the reaction coordinate, to
explain the substrate specificity of this enzyme, and to ration-
alize and model mutants of this enzyme designed to modify the
substrate selectivity.
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